ClinicalTrials.gg
RecruitingNCT07216599Updated Nov 19, 2026

Photoacoustic Imaging of Foot Wound

An interventional study of Photoacoustic imaging and multispectral imaging in Foot Ulcer, sponsored by State University of New York at Buffalo. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by State University of New York at Buffalo · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year later.
Updated Nov 19, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 90 studies in Foot Ulcer with a site in United States — 21 open to participants now, 22 under way, 1 of them phase 3. Foot Ulcer · United States.

Planned enrollment
58th of 75
25 · median 60
Started
2025
with 7 others
No phase
39 of 90
12 open now
Primary completion
2027-04
later than 13 of 21 live
Registered
87th of 90
by date

Among the 90 studies in Foot Ulcer with a site in United States, this one is the 58th largest by planned enrollment of the 75 interventional ones that give a count, is one of 8 that started in 2025, is one of 39 with no phase, reaches primary completion later than 13 of the 21 other live ones, and was the 87th registered.

Foot Ulcer

196 studies on the registry are indexed under Foot Ulcer; 43 are open to participants now.

Browse Foot Ulcer studies →

Open to participants now

21 of the 90 studies in Foot Ulcer with a site in United States are open now. Recruiting first, the newest first:

15 more — sign in →

All 21 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 32 Foot Ulcer studies recruiting now, 27 (84%) set no upper age limit and 2 (6%) stop at 75 or younger; none take children under 18; none take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 90 studies in Foot Ulcer with a site in United States, or all of them as a file.
02

Study summary

This pilot device trial aims to test the feasibility of using photoacoustic images to monitor tissue perfusion and to guide post-surgical wound treatment. Through this pilot study, the investigators will test the feasibility, identify any practical issues, and acquire essential information (e.g., drop-off rate, variation in wound healing rate) to guide future large-scale studies.

Read the detailed description

This pilot device trial aims to test the feasibility of using photoacoustic images to monitor tissue perfusion and to guide post-surgical wound treatment. Through this pilot study, the investigators will test the feasibility, identify any practical issues, and acquire essential information (e.g., drop-off rate, variation in wound healing rate) to guide future large scale studies.

For recruited patients, wound care will be guided by both photoacoustic imaging and Kent imaging, a multi-spectral imaging technique for tissue oxygenation mapping. None of the techniques is currently used in the clinic as standard care.

03

Conditions studied

  • Foot Ulcer

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with a chronic wound on the foot that is presumed to be due to arterial insufficiency.

Exclusion criteria

Exclusion Criteria:

  • Patients with a massive deep tissue infection.
  • Patients with preexisting skin conditions, such as melanoma, psoriasis, in areas close to the wound(s).
  • Noncompliant patients who do not adhere to care plans.
  • Pregnant women.
  • Adults unable to consent.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Single study arm

    Participants will undergo imaging using the investigational photoacoustic device.

    Device: Photoacoustic imaging and multispectral imaging

Interventions

  • DevicePhotoacoustic imaging and multispectral imaging

    Use photoacoustic and Kent imaging devices that can image vasculature and assess tissue perfusion on the foot.

06

What researchers measure

Primary outcomes

  1. Treatment fidelity rate

    The ratio of cases received additional clinical assessment due to photoacoustic imaging results.

    Time frame: 12 months

  2. Percentile healing score

    The healing score will be defined as the ratio of the healed wound area versus the pre-treatment wound area (1-(post-treatment wound area)/(pre-treatment wound area)). A percentile healing value of 100% indicates that the wound is fully healed, while a value of 0% indicates that the wound area does not change.

    Time frame: 12 months

Secondary outcomes

  1. Recruitment rate

    The ratio of recruited patients to the total number of eligible patients

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
  • UBMD Vascular Surgery
    Buffalo, New York 14221, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Apr 2027, 18 months after the start.

Of 36 non-industry interventional studies with no phase under Foot Ulcer, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 43. This study's planned 18 months is below that.

Counting every sponsor, half of 56 studies reached it within 25 months; a quarter within 9 and three quarters within 40.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: primary completion Sep 2026 → Apr 2027 and completion Dec 2026 → May 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2025
First posted
Oct 14, 2025
StartActual
Oct 28, 2025
Primary completionEst.
Apr 30, 2027was Sep 2026
CompletionEst.
May 31, 2027was Dec 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 30, 2026→Apr 30, 2027
Nov 19, 2026
Study completion
Dec 31, 2026→May 31, 2027
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Primary completion Sep 30, 2026→Apr 30, 2027
    Study completion Dec 31, 2026→May 31, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07216599
Responsible party
Jun Xia, Ph.D. (Principal Investigator, State University of New York at Buffalo) — Principal investigator
First posted
Oct 14, 2025
Start date
Oct 28, 2025
Primary completion
Apr 30, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Jun Xia, Ph.D.
Contact
junxia@buffalo.edu
716-645-8628

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion